Advanced

Claudin-2 is an independent negative prognostic factor in breast cancer and specifically predicts early liver recurrences.

Kimbung, Siker LU ; Kovács, Anikó; Bendahl, Pär-Ola LU ; Malmström, Per LU ; Fernö, Mårten LU ; Hatschek, Thomas and Hedenfalk, Ingrid LU (2014) In Molecular Oncology 8(1). p.119-128
Abstract
Predicting any future metastatic site of early-stage breast cancer is important as it significantly influences the prognosis of advanced disease. This study aimed at investigating the potential of claudin-2, over-expressed in breast cancer liver metastases, as a biomarker for predicting liver metastatic propensity in primary breast cancer.
Please use this url to cite or link to this publication:
author
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
Molecular Oncology
volume
8
issue
1
pages
119 - 128
publisher
Elsevier
external identifiers
  • pmid:24287398
  • wos:000331510100012
  • scopus:84892986572
ISSN
1574-7891
DOI
10.1016/j.molonc.2013.10.002
language
English
LU publication?
yes
id
53001014-6e46-49f6-861e-e0b793e67526 (old id 4178805)
alternative location
http://www.ncbi.nlm.nih.gov/pubmed/24287398?dopt=Abstract
date added to LUP
2013-12-02 18:00:31
date last changed
2017-11-12 03:05:39
@article{53001014-6e46-49f6-861e-e0b793e67526,
  abstract     = {Predicting any future metastatic site of early-stage breast cancer is important as it significantly influences the prognosis of advanced disease. This study aimed at investigating the potential of claudin-2, over-expressed in breast cancer liver metastases, as a biomarker for predicting liver metastatic propensity in primary breast cancer.},
  author       = {Kimbung, Siker and Kovács, Anikó and Bendahl, Pär-Ola and Malmström, Per and Fernö, Mårten and Hatschek, Thomas and Hedenfalk, Ingrid},
  issn         = {1574-7891},
  language     = {eng},
  number       = {1},
  pages        = {119--128},
  publisher    = {Elsevier},
  series       = {Molecular Oncology},
  title        = {Claudin-2 is an independent negative prognostic factor in breast cancer and specifically predicts early liver recurrences.},
  url          = {http://dx.doi.org/10.1016/j.molonc.2013.10.002},
  volume       = {8},
  year         = {2014},
}